Showing results (1061-1070 of 2,331) with videos related to
Sort By:
Pageof 234
Clinical Drug Investigation|October 31, 2012
Pharmacokinetics and safety of ezetimibe/simvastatin combination tablet: an open-label, single-dose study in healthy Chinese subjectsNan-Nan Chu, Wei-Li Chen, Hong-Rong Xu, et al.Clinical Drug Investigation|January 9, 2014
The pharmacokinetic and safety profiles of blonanserin in healthy Chinese volunteers after single fasting doses and single and multiple postprandial dosesXia Chen, Hongyun Wang, Ji Jiang, et al.Clinical Drug Investigation|November 10, 2012
Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucomaJordana K Schmier, David W Covert, Edmund C LauClinical Drug Investigation|January 29, 2014
Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-upXiaohan Xu, Weijun Zhang, Yujie Zhou, et al.Clinical Drug Investigation|August 10, 2012
Current status of hepatocellular carcinoma treatment in Japan: transarterial chemoembolizationOsamu MatsuiClinical Drug Investigation|August 10, 2012
Current status of hepatocellular carcinoma treatment in Japan: hepatic arterial infusion chemotherapyTatsuya YamashitaClinical Drug Investigation|October 3, 2012
Comparative pharmacokinetics/pharmacodynamics of clopidogrel besylate and clopidogrel bisulfate in healthy Korean subjectsBo-Hyung Kim, Jung-Ryul Kim, Kyoung Soo Lim, et al.Clinical Drug Investigation|October 3, 2012
Lifetime cost-utility analyses of deferasirox in beta-thalassaemia patients with chronic iron overload: a UK perspectiveJonathan Karnon, Keith Tolley, Joao Vieira, et al.Clinical Drug Investigation|October 3, 2012
Achieving and sustaining remission in bipolar I disorder with ziprasidone : a post hoc analysis of a 24-week, double-blind, placebo-controlled studyChi-Un Pae, Prakash S Masand, Francine S Mandel, et al.Clinical Drug Investigation|September 29, 2012
A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophreniaSeung Jae Lee, Jong Hun Lee, Sung Won Jung, et al.Pageof 234